Redesigned clinical trials
In 2020, applicants can expect innovation in the field of clinical trials, including more virtual or hybrid trials, adaptive trials, and other designs that better meet patient needs. In fact, the company is realizing the value of patient insights (as well as other stakeholders) for successfully conducting experiments.
|In 2020, sponsors can expect innovation in clinical trials, including more virtual or hybrid trials, adaptive trials, and other designs that better meet patient needs. In fact, companies are realizing the value of patient insights (and other stakeholders) for successful trial execution.
|Trials are also more complicated than ever. The amount of data that sponsors can use is a blessing in disguise – more insight can lead to more effective treatments, but disparate data sources present significant challenges for accurate, timely analysis. Advanced digital tools promise to simplify clinical data management, reduce costs and accelerate study completion times.
|At the 2019 Drug Information Association (DIA) Global Annual Conference, Xtalks spoke with industry professionals to gain more insight into the future of clinical trials.